STAT
JULY 12, 2023
The nation’s widespread racial health disparities won’t be erased without changes to how health care systems are funded and accredited, more public and financial accountability for poor patient outcomes, and more work to overturn the income inequality and residential segregation tied to poorer health and lower life expectancy for many people who are Black and brown.
PharmaVoice
JULY 12, 2023
A new psychedelic guidance from the agency gives a clue into how it could analyze drugs in the space, but industry leaders are eager for more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 12, 2023
One year after 988 launched as the new number for the national U.S. mental health hotline, the people behind the system say they’re still working out some kinks. In an ideal world, for example, a caller in New York looking to talk would be routed to a New York call center, so that hotline workers could direct them to the most relevant information on local resources.
Pharma Marketing Network
JULY 12, 2023
The internet is a vast resource of information on health and wellness. However, not all of this information is created equal. Some of it is accurate and reliable, while other information may be misleading or even harmful. This is especially true when it comes to pharmaceutical-sponsored health information. Pharmaceutical companies have a vested interest in promoting their products, so it’s important to be critical of any information they put out.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 12, 2023
The treatment of sickle cell disease is on the cusp of a historic breakthrough, with makers of two gene-based treatments for the debilitating blood disorder hoping for regulatory approval this year. But for those with sickle cell in sub-Saharan Africa, where more than 60% of the 120 million people worldwide live with this disease, there is little cause to celebrate.
PharmExec
JULY 12, 2023
Recent data and commentary offer insights into how biologics vs. small molecule patent protections under the Inflation Reduction Act pricing scenarios is impacting investing in the biotech sector.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Marketing Network
JULY 12, 2023
The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs.
STAT
JULY 12, 2023
WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment , insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests. Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease.
The Pharmacist
JULY 12, 2023
Observational and randomised trial findings provide conflicting evidence over whether supplementing with vitamin D may benefit heart health in older adults. Do the findings of a recent randomised trial now offer patients a clearer picture? Rod Tucker takes a closer look, in the next topic examined in our Review series. Research into the benefits of […] The post Should older adults take vitamin D to protect their heart?
STAT
JULY 12, 2023
Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
JULY 12, 2023
The decision to explore “strategic alternatives” comes about six weeks after the company sold its most advanced treatment to Novartis for nearly $90 million.
STAT
JULY 12, 2023
There are alarmingly frequent reports of shortages of vitally needed medicines. From tablets to treat ADHD and severe pain to injectable treatments for syphilis and various cancers, the U.S. has been facing a number of serious shortages recently. And this was before a U.S. Senate report found the number of active shortages reached a peak at 295 at the end of 2022.
National Association of Boards of Pharmacy
JULY 12, 2023
Careers in pharmacy involve lifelong learning and adaptation to new situations. In this feature, a Virginia pharmacy inspector discusses her ever-changing role in the field. Amy Branson, PharmD, RPh Pharmacy Inspector, Virginia Department of Health Professions How long have you been serving as a pharmacy inspector for the Board? What was your prior role?
STAT
JULY 12, 2023
LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators. The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations.
Pharma Times
JULY 12, 2023
Company adds a number of additional brands from Sanofi following initial take overs in 2021 - News - PharmaTimes
BioPharma Dive
JULY 12, 2023
The European drug regulator says it now has 150 reports of possible cases involving self-injury and suicidal thoughts among people taking GLP-1 medicines like Ozempic.
European Pharmaceutical Review
JULY 12, 2023
The first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa, has been prequalified by the World Health Organization (WHO). MenFive ® has been developed through a 13-year collaboration between the world’s largest vaccine manufacturer Serum Institute of India Pvt. Ltd. (SIIPL) and PATH, with funding from the UK government.
BioPharma Dive
JULY 12, 2023
Backed by F-Prime Capital and Sofinnova Partners, the company claims to have technology that could allow it replace eye cells destroyed in age-related and inherited ocular conditions.
PhRMA
JULY 12, 2023
This week, PhRMA submitted comments to the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) regarding the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization draft. In our comments, we expressed our strong opposition to policy proposals that would inhibit the biopharmaceutical industry partnering with the government to address pressing public health needs.
Pharmaceutical Commerce
JULY 12, 2023
Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26,500 a year.
Outsourcing Pharma
JULY 12, 2023
Lisa Moneymaker is full of energy, enthusiasm, and wisdom. She is well-known on the pharma circuit and itâs easy to see why. She has been chief technology officer and chief product officer at Saama since October last year and feels passionately about women in science and women in general â and although her journey was without many challenges, she appreciates that is not the case for everyone.
Pharmaceutical Commerce
JULY 12, 2023
AmerisourceBergen’s new 34,000 square-foot plant in Chicago area will support shipments that require temperature storage/delivery as cold as cryogenic.
epicur
JULY 12, 2023
Cancer in veterinary patients is, unfortunately, a common occurrence. One in five cats and almost fifty percent of dogs over age ten develop cancer, and because it is often not diagnosed in its early stages, it carries a high mortality risk. However, advancements in veterinary oncology care are making it possible to detect cancer more quickly and treat it more effectively, improving patient outcomes.
Pharma Times
JULY 12, 2023
The company aims to deliver therapies that provide benefits to patients affected by eye diseases - News - PharmaTimes
Pharmaceutical Technology
JULY 12, 2023
Innovate UK’s New Cancer Therapeutics programme awarded the grant to the Imperial College spinout to support pre-clinical development.
Express Pharma
JULY 12, 2023
June is the Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, and Director of the Parker Institute for Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania Foundation DKMS Stiftung Leben Spenden honors Professor Carl H. June for his outstanding achievements in cancer immunology with the DKMS Mechtild Harf Science Award 2023.
Pharmaceutical Technology
JULY 12, 2023
The EMA is reviewing data on the potential effects of high-profile GLP-1RAs in causing suicidal thoughts and thoughts of self-harm.
Express Pharma
JULY 12, 2023
The tour was aimed at encouraging medical students to explore new horizons in their academic journey Glenmark Pharma hosted MBBS students at one of its R&D centers in Mumbai for a special workshop on drug discovery. The workshop is part of Lokmanya Tilak Municipal Medical College’s (LTMMC) Trinity event that brings together over 3000 MBBS student delegates from across the country and around the world.
Outsourcing Pharma
JULY 12, 2023
Acasti Pharma, a late-stage biopharma company with drug candidates addressing rare and orphan diseases, has selected WuXi Clinical Development to conduct its STRIVE-ON phase 3 safety trial for GTX-104, a novel injectable nimodipine formulation for intravenous infusion (IV) that addresses high, unmet medical needs for aneurysmal subarachnoid haemorrhage (aSAH).
Express Pharma
JULY 12, 2023
Ten individuals will be awarded prizes totalling Rs 2,250,000 Merck has announced its third edition of the Merck Young Scientist Award 2023 to recognise young scientists in India. This award traditionally acknowledges young scientists from academia, who are making a difference in the lives of millions across India, through their cutting-edge research in life sciences.
Outsourcing Pharma
JULY 12, 2023
Ora, a clinical research organization (CRO) for ophthalmology pharmaceutical and device development, has partnered the North West London Clinical Trials Alliance, to improve the quality and access to clinical research in the region.
Express Pharma
JULY 12, 2023
The Primary Executive Officer for Healthcare and staff will be located in existing Asahi Kasei offices in Chelmsford, Massachusetts, a suburb of Boston Asahi Kasei announced that it is moving the global headquarters for its healthcare business to the United States. The Primary Executive Officer for healthcare and staff will be located in existing Asahi Kasei offices in Chelmsford, Massachusetts, a suburb of Boston.
Pharmaceutical Technology
JULY 12, 2023
To that end, the company presented positive top-line Phase III results for its once-daily stimulant for ADHD.
Express Pharma
JULY 12, 2023
GenAI is set to revolutionise drug discovery by generating novel drug candidates based on researcher-provided criteria and constraints The implementation of Generative Artificial Intelligence (GenAI) in pharma and healthcare has the potential to address the issues of high costs and poor patient experiences while enhancing efficiency and patient outcomes.
Outsourcing Pharma
JULY 12, 2023
2San, a supplier of self-diagnostic tests, has partnered with Proov to distribute their proprietary at-home fertility tests in select Hy-Vee stores across eight states in the Midwest.
Expert insights. Personalized for you.
231 
Let's personalize your content